Drug and Therapeutics Committees - A Practical Guide
(2003; 155 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentAcronyms and abbreviations
Afficher le documentPreface
Ouvrir ce répertoire et afficher son contenu1. Introduction
Ouvrir ce répertoire et afficher son contenu2.Structure and organization of a drug and therapeutics committee
Ouvrir ce répertoire et afficher son contenu3. Managing the formulary process
Ouvrir ce répertoire et afficher son contenu4.Assessing new medicines
Ouvrir ce répertoire et afficher son contenu5.Ensuring medicine safety and quality
Ouvrir ce répertoire et afficher son contenu6.Tools to investigate the use of medicines
Ouvrir ce répertoire et afficher son contenu7.Promoting the rational use of medicines
Ouvrir ce répertoire et afficher son contenu8.Antimicrobials and injections
Ouvrir ce répertoire et afficher son contenu9. Getting started
Afficher le documentGlossary1
Afficher le documentReferences
Afficher le documentFurther reading
Afficher le documentUseful addresses and websites
Afficher le documentBack cover
 

Further reading

American Society of Health-System Pharmacists (1992) Guidelines on formulary system management. American Journal of Hospital Pharmacy 49: 648-652.

American Society of Health-System Pharmacists (1992) ASHP statement on the pharmacy and therapeutics committee. American Journal of Hospital Pharmacy 49: 2008-2009.

British Medical Association and Royal Pharmaceutical Society of Great Britain (ongoing) British national formulary, updated 6-monthly. BMJ Books, London.

Gehlbach, SH (1993) Interpreting the medical literature, 3rd edn. McGraw-Hill, New York,

Hogerzeil HV, Ross-Degnan R, Laing RO, et al. (1993) Field tests for rational drug use in twelve developing countries. Lancet 342: 1408-10.

Management Sciences for Health (1997) Managing drug supply, 2nd edn. Kumarian Press, West Hartford, CT. ISBN: 1-56549-047-9. See especially chapter 3, ‘Economics for drug management’; chapter 29 ‘Investigating drug use’, chapter 30, ‘Drug and therapeutics information’, chapter 31 ‘Promoting rational prescribing’; chapter 38, ‘Hospital drug services’; chapter 41, ‘Analysing and controlling drug expenditures’; Part III Section A, ‘Selection’.

Prüss A, Giroult E, Rushbrook P (1999) Safe management of wastes from health care activities. World Health Organization, Geneva.

Sanchez LA (1999) Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature. American Journal of Health System Pharmacy 56(16): 1630-1638.

South African medicines formulary (1998) 3rd edn. Medical Association of South Africa Publications, Cape Town.

WHO (1988) Estimating drug requirements: a practical manual. World Health Organization, Geneva. WHO/ DAP/88.2.

WHO (1992) Injection practices research. World Health Organization, Geneva. WHO/DAP/92.6.

WHO (1994) Injection practices: a case study of Thailand. World Health Organization, Geneva. WHO/DAP/ 94.8.

WHO (1994) WHO ethical criteria for medicinal drug promotion: report by the Director-General. World Health Organization, Geneva.

WHO (1996) Injection practices in the developing world: a comparative review of field studies in Uganda and Indonesia. World Health Organization, Geneva. WHO/DAP/96.4.

WHO (2000) Operational principles for good pharmaceutical procurement: supply and marketing. Interagency guidelines. World Health Organization, Geneva. WHO/EDM/PAR/99.5.

WHO (2001) WHO global strategy for the containment of antimicrobial resistance. Department of Communicable Disease and Response, Drug Resistance Surveillance, World Health Organization, Geneva.

WHO (2001) Teachers guide to good prescribing. World Health Organization, Geneva. WHO/EDM/PAR/2001.2.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013